INTRODUCTIONPelvic exenteration surgery, used to treat advanced gastrointestinal, gynecologic, and urologic malignancy, is an extensive surgery that involves en bloc removal of the pelvic viscera. A total pelvic exenteration in a male includes removal of the rectum, bladder, and prostate/seminal vesicles if present. In a female patient, a total pelvic exenteration includes removal of the bladder, vagina (part or complete), uterus if present, and rectum. Although pelvic exenteration has significant advantages for longer disease‐free and overall survival, its associated perioperative complications, including hemorrhage and infections, can negatively impact a patient's postoperative course.Wound infection is one of the most common postoperative complications. In patients who underwent pelvic exenteration, estimated infection rates were up to 30‐43%, and the rate of pelvic abscess was reported to be 6‐20%. These complications can affect quality of life, impact recovery, prolong hospital length of stay (LOS), and increase the readmission rate. Prolonged hospitalization and readmissions also can increase overall healthcare costs. However, few studies have assessed the risk factors for prolonged LOS in patients who undergo pelvic exenteration. We know of only such one study, which showed that longer hospital LOS after pelvic exenteration was associated with lower body mass index (BMI).The primary aim of
Journal of Surgical Oncology – Wiley
Published: Jan 1, 2018
Keywords: ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera